{
    "nctId": "NCT03050463",
    "briefTitle": "Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer",
    "officialTitle": "Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions",
    "overallStatus": "COMPLETED",
    "conditions": "Healthy Subject, Stage 0 Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 178,
    "primaryOutcomeMeasure": "Explicit Affect Reactivity and Regulation Measured Using functional MRI (fMRI) Reactivity Probes",
    "eligibilityCriteria": "Inclusion Criteria:\n\nWomen Diagnosed with breast cancer\n\n* Female\n* Age 18 or older\n* Agree to suspend treatments containing Benzodiazepines and steroids up to 2 weeks pre and during cortisol sampling (based on PI's clinical judgement)\n* Agree to taking saliva samples and having fMRI scan\n* No contraindications to MRI imaging (like ferromagnetic metal in their body)\n* Proficiency in English sufficient to complete questionnaires and follow instructions during the fMRI assessments\n* US Citizen or resident able to receive payment legally\n* Documented stage 0-III breast cancer\n* Unilateral breast tumors\n\nControls\n\n* Female\n* Age 18 or older\n* Agree to suspend treatments containing Benzodiazepines and steroids up to 2 weeks pre and during cortisol sampling (based on PI's clinical judgement)\n* Agree to having saliva samples and fMRI scan\n* No contraindications to MRI imaging (like ferromagnetic metal in their body)\n* Proficiency in English sufficient to complete questionnaires and follow instructions during the fMRI assessments\n* US Citizen or resident able to receive payment legally\n\nExclusion Criteria:\n\nWomen Diagnosed with breast cancer\n\n* Other active cancers within the past 10 years other than squamous cell carcinoma of the skin\n* Pregnant\n* Any significant neurologic disease, such as dementia, multi-infarct dementia, Parkinson's or Huntington's disease, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, stroke, or traumatic brain injury\n* Hearing impaired\n* Current untreated psychosis, or bipolar disorder, or substance/alcohol abuse/dependence\n* Current use of psychotropic (based on PI's clinical judgement) medication 5 or more days a week\n\nControls\n\n* Cancer diagnosis, current or past\n* Pregnant\n* Any significant neurologic disease, such as dementia, multi-infarct dementia, Parkinson's or Huntington's disease, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, stroke, or traumatic brain injury\n* Hearing impaired\n* Current untreated psychosis, or bipolar disorder, or substance/alcohol abuse/dependence\n* Current use of psychotropic (based on PI's clinical judgement) medication 5 or more days a week\n* Breast cancer diagnosis in 1 first degree relative or 2 or more second degree relatives\n* Ovarian cancer diagnosis in 1 first or second degree relative",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}